Resources

Excess mortality, common among Medicare-age diabetics, is greatest for women who use insulin to control their diabetes, according to an analysis of data from the Cardiovascular Health Study.

Consuming nuts, especially tree nuts, showed a powerful dose-response protective effect against coronary heart disease mortality in the largest-ever prospective cohort study focusing on the relationship between diet, cancer, and cardiovascular disease.

One-hour OGTT glucose concentrations rise significantly with age even in subjects with NGT.

Every kilogram of weight loss resulted in 16% reduction of diabetes risk.

Dr Emilio Ros, Hospital Clínico, Barcelona, Spain, explains “When we eat a fatty meal, inflammatory molecules are increased that prevent the endothelium from producing nitric oxide, which thus leads to endothelial dysfunction. In our study, eating a handful of walnuts prevented the increase in the inflammatory substances and the endothelial …

Diabetes in Control interviewed Novocells’ Chief Scientific Officer, Emmanual Baetge and he told us that they have determined the necessary conditions for turning human embryonic stem cells into insulin-producing cells, a finding that moves the prospect of using these cells to treat diabetes closer to the clinic.

A new drug billed as a magic bullet for obesity — rimonabant (Acomplia) — does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.

Study finds a sixfold higher threat of pulmonary embolism after hip or knee replacements.

Breast-feeding is inversely associated with the risk of childhood obesity regardless of maternal diabetes status or weight status.

Metformin taken by women with polycystic ovary syndrome (PCOS) during the first trimester of pregnancy does not appear to increase the risk of major fetal malformations, and may have a significant protective effect.